The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients

被引：0
作者：
Azhar M. Nomair
Abeer Abdelati
Fatma I. Dwedar
Rehab Elnemr
Yasmine N. Kamel
Hanan M. Nomeir
机构：
[1] Alexandria University,Department of Chemical Pathology, Medical Research Institute
[2] Alexandria University,Department of Internal Medicine, Rheumatology and Clinical Immunology Unit, Faculty of Medicine
[3] Alexandria University,Department of Medical Biochemistry, Faculty of Medicine
[4] Alexandria University,Department of Physical Medicine Rheumatology and Rehabilitation, Faculty of Medicine
来源：
Clinical Rheumatology | 2024年 / 43卷
关键词：
ATIC; Methotrexate; RFC-1; Rheumatoid arthritis; TYMS; Variant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：971 / 983
页数：12
相关论文
共 50 条
[41]   Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis [J].
M Drozdzik ;
T Rudas ;
A Pawlik ;
W Gornik ;
M Kurzawski ;
M Herczynska .
The Pharmacogenomics Journal, 2007, 7 :404-407
[42]   Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate [J].
Kempe, K ;
Tsuda, H ;
Yang, KS ;
Yamaji, K ;
Kanai, Y ;
Hashimoto, H .
THERAPEUTIC APHERESIS AND DIALYSIS, 2004, 8 (03) :197-205
[43]   Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy [J].
Baraldo, M ;
Ferraccioli, G ;
Pea, F ;
Gremese, E ;
Furlanut, M .
PHARMACOLOGICAL RESEARCH, 1999, 40 (06) :483-486
[44]   Effect of Methotrexate therapy on B and activated T cells on rheumatoid arthritis patients [J].
Boroujerdnia, Mehri Ghafourian ;
Mola, Karim ;
Hemmati, Ali Asghar ;
Hajmohammady, Mohammad .
TOXICOLOGY LETTERS, 2008, 180 :S211-S212
[45]   Folate Conjugated Double Liposomes Bearing Prednisolone and Methotrexate for Targeting Rheumatoid Arthritis [J].
Verma, Amit ;
Jain, Ankit ;
Tiwari, Ankita ;
Saraf, Shivani ;
Panda, Pritish K. ;
Agrawal, G. P. ;
Jain, Sanjay K. .
PHARMACEUTICAL RESEARCH, 2019, 36 (08)
[46]   Predicting methotrexate resistance in rheumatoid arthritis patients [J].
Yu, Mary Beth ;
Firek, Anthony ;
Langridge, William H. R. .
INFLAMMOPHARMACOLOGY, 2018, 26 (03) :699-708
[47]   Methotrexate for rheumatoid arthritis patients who are on hemodialysis [J].
Al-Hasani, Hasanein ;
Roussou, Euthalia .
RHEUMATOLOGY INTERNATIONAL, 2011, 31 (12) :1545-1547
[48]   Determinants of methotrexate adherence in rheumatoid arthritis patients [J].
De Cuyper, Ellen ;
De Gucht, Veronique ;
Maes, Stan ;
Van Camp, Yoleen ;
De Clerck, Luc S. .
CLINICAL RHEUMATOLOGY, 2016, 35 (05) :1335-1339
[49]   Treatment of rheumatoid arthritis with methotrexate in Congolese patients [J].
Malemba, J. J. ;
Muamba, J. M. Mbuyi ;
Mukaya, J. ;
Bossuyt, X. ;
Verschueren, P. ;
Westhovens, R. .
CLINICAL RHEUMATOLOGY, 2013, 32 (09) :1323-1327
[50]   Nodules in patients with rheumatoid arthritis and methotrexate treatment [J].
Nakamura, Tadashi ;
Inaba, Megumi ;
Yoshinaga, Takeshi ;
Takaoka, Hirokazu ;
Iyama, Ken-ichi .
MODERN RHEUMATOLOGY, 2015, 25 (05) :812-813
12345